BOULDER, Colo.--(BUSINESS WIRE)--Sep. 11, 2012--
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Ron Squarer, will speak at the UBS Global Life
Sciences Conference in New York City. The public is welcome to
participate in the conference through a webcast on the Array BioPharma
website.
|
Event:
|
|
|
|
UBS Global Life Sciences Conference
|
|
Presenter:
|
|
|
|
Ron Squarer, Chief Executive Officer
|
|
Date:
|
|
|
|
Thursday, September 20, 2012
|
|
Time:
|
|
|
|
8:30 a.m. Eastern Time
|
|
Location:
|
|
|
|
The Grand Hyatt New York, NY
|
|
Webcast:
|
|
|
|
www.arraybiopharma.com
|
|
|
|
|
|
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small-molecule
drugs to treat patients afflicted with cancer. Array is evolving into a
late-stage development company, with two wholly-owned programs, ARRY-614
and ARRY-520, and three partnered programs, selumetinib (with
AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune /
Roche), having the potential to begin Phase 3 or pivotal trials by the
end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.
Source: Array BioPharma Inc.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
View printer-friendly version
